A detailed history of Entropy Technologies, LP transactions in Innoviva, Inc. stock. As of the latest transaction made, Entropy Technologies, LP holds 11,482 shares of INVA stock, worth $243,073. This represents 0.02% of its overall portfolio holdings.

Number of Shares
11,482
Previous 14,298 19.7%
Holding current value
$243,073
Previous $248 Million 16.08%
% of portfolio
0.02%
Previous 0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025

SELL
$17.21 - $18.98 $48,463 - $53,447
-2,816 Reduced 19.7%
11,482 $208 Million
Q4 2024

Jan 28, 2025

BUY
$17.35 - $20.32 $248,070 - $290,535
14,298 New
14,298 $248 Million

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.48B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Entropy Technologies, LP Portfolio

Follow Entropy Technologies, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Entropy Technologies, LP, based on Form 13F filings with the SEC.

News

Stay updated on Entropy Technologies, LP with notifications on news.